20.22 USD
↘ 0.02 (0.12%)PRE MARKET (AS OF 05:02 AM EST)
Shares of Nuvectis Pharma, Inc. Common Stock (NVCT) are trading at $20.22. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. NVCT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.